Recently in myeloproliferative disorders and myeloid malignancies researches, researchers discover JAK2 in the nuclear region of hematopoietic cells, and JAK2 nuclear translocation has been linked to conditions associated with high cell turnover in hematopoietic cells [16]. Here, JAK2 is linked to myeloproliferative disorder.